Please provide your email address to receive an email when new articles are posted on . In the world of technology, disruptors are sought-after and celebrated. When Roy S. Rubinfeld, MD, MA, led the ...
Glaukos Corporation GKOS recently announced the commercial availability of Epioxa, marking a significant milestone in its corneal health portfolio. The therapy stands out as the first FDA-approved, ...
Please provide your email address to receive an email when new articles are posted on . In our OD-MD practice, cross-linking is performed in-house, and the optometrists do the bulk of the work in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results